Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance

1. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Шарҳ мақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 иқтибос

   ABIABI:AkademIndex/openalex/2017.review-article.000004

2. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   МақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.000020

3. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

   Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

   МақолаTuberculosis Research and EpidemiologyERJ Open Research20201 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.360284